ELIZABETH NEWSOM: Open Payments
NPI 1316530074 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$159 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $79 · 2025 $159
Food & beverage: $159
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Dexcom, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| ABBVIE INC. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
Products named: FARXIGA, Dexcom G6 Transmitter, REXULTI, ZENPEP, CAPLYTA, AIRSUPRA, UBRELVY, VOQUEZNA.
Industry payments across SC — which companies pay providers there.
